Substances

Sherine El-Toukhy leverages digital technologies to improve access to healthcare.

Lorenzo Leggio seizes new opportunities to develop treatments for substance use disorders.

The diabetes medication known as Ozempic has captured public attention since it was approved by the U.S. Food and Drug Administration (FDA) for weight management in 2021. It has garnered appeal as a wonder drug against obesity and provided much fodder for celebrity gossip, but accounts from people on the drug have piqued the interest of certain scientists and clinicians for different a reason.

Geoffrey Schoenbaum investigates how our insight (or lack thereof) shapes behavior.

Jerrel Yakel studies the neural circuits that underlie learning and memory.

Paule Joseph explores how variations in taste and smell might contribute to obesity and addiction.

Veronica Alvarez takes the path less traveled to understand addiction.

Bin Gao probes the immune system to prevent and treat advanced liver disease.